CloudCath and Competitor Overview
CloudCath Overview
CloudCath is a trailblazing medical device company established in 2017 and headquartered in San Francisco, California. With a core focus on enhancing health outcomes for patients requiring catheterization, CloudCath has integrated cutting-edge fluid analytics and remote monitoring technologies to address infectious diseases in real-time. The company's flagship product, CloudCath Connect™ PD, combines optical analysis with IoT devices and cloud computing, offering continuous patient monitoring for those undergoing peritoneal dialysis (PD). This solution provides real-time notifications to healthcare providers and patients, enabling early detection of complications such as peritonitis and thus improving adherence to home PD treatments.
Leadership Team
- Aly ElBadry: CEO & Co-Founder; MBA from Stanford University Graduate School of Business. Key achievements include national reimbursement approval for CloudCath’s products.
- Chris Pell: Head of New Product Introduction; notable for extensive product development expertise within the medical device industry.
- Eric Yu: Chief Technology Officer & Co-Founder; instrumental in technological advancements of CloudCath’s offerings.
- Mayya Yukilevich: Vice President of Business Development; adept in healthcare innovation and strategic business growth.
- Don Williamson: Chief Medical Officer & EVP of Clinical Operations; brings 30 years of experience from roles like COO at American Renal Associates.
- Kelly Constable: Chief Operating Officer; a leader in commercialization with over 20 years of experience.
Key Facts and Achievements
- Annual Revenue: $6 million
- Employee Count: 24
- Funding: Successfully raised $12 million in a Series A funding round in February 2020.
- Collaborations: Active partnership with healthcare entities such as American Renal Associates for improving remote monitoring solutions.
Technological Impact
CloudCath’s platform represents a significant advancement in the management of home-based dialysis care by enabling early diagnostics for potential complications—critical in reducing hospitalizations and improving patient outcomes. The system sends timely alerts to both patients and healthcare providers upon detecting significant changes in dialysate fluid.
Contact Information
- Address: 665 3rd St. Suite 250, San Francisco, CA 94107
- Phone: 877-664-6555
- Email: info@cloudcath.com
- Website: [CloudCath](https://www.cloudcath.com/)
Competitive Landscape
CloudCath operates in a competitive market within the health technology and medical device sectors. Key competitors include:
Aperio Technologies
A leader in the field of digital pathology, Aperio Technologies provides comprehensive solutions for the digitization and management of pathology images. They cater to hospitals, reference labs, and research institutions globally, enhancing data management through AI-driven industrial data solutions. Headquartered in Boston, they ensure improved data accuracy with their innovative technology.
Monobind Inc.
Established in 1978 and based in Lake Forest, California, Monobind Inc. leads in the diagnostic development field. They offer innovative and cost-effective IVD kits, enhancing health diagnostics with a focus on thyroid, fertility, anemia, diabetes, and infectious diseases. Their products, complying with ISO 13485 and FDA standards, serve a global market in over 110 countries.
Lief Therapeutics
Lief Therapeutics develops wearable devices that support mental health management through biofeedback technology, allowing users to monitor heart rate variability (HRV) to manage conditions like PTSD, depression, and anxiety. This positions them as a pioneering company in the medical wearables space.
Amwell
Amwell, a telemedicine company headquartered in Boston, Massachusetts, facilitates healthcare delivery through a robust digital platform. Their services enhance accessibility and effectiveness in healthcare by offering virtual and automated care, supporting approximately 2,300 active providers and health systems.
Cureatr
Cureatr's cloud-based medication management software optimizes patient care by connecting various stakeholders within the healthcare continuum. Headquartered in New York, Cureatr focuses on improving medication management and outcomes.
Competitive Edge and Positioning
CloudCath differentiates itself by focusing on niche patient segments, particularly in peritoneal dialysis care, offering specialized medical devices that cater to specific needs often overlooked by broader-market competitors. Strategic partnerships with healthcare providers and dedication to remote monitoring technologies uniquely position CloudCath to strengthen its market presence.
By understanding its competitors and strategic dynamics in the health technology industry, CloudCath can refine its strategic objectives and align product development and marketing efforts to emphasize its unique value propositions in quality care and monitoring, advancing its position in a competitive market.
